INFECTION IMMUNITY, Feb. 2009, p. 860â€“866                                                                                      Vol. 77,  2
0019-9567/09/$08.00â«¹0 doi:10.1128/IAI.00995-08
Copyright Â© 2009, American Society Microbiology. Rights Reserved.



  Host Glycosaminoglycan Confers Susceptibility Bacterial Infection
                     Drosophila melanogasteräŒ¤
Miriam J. Baron,1* Sandra L. Wong,1 Kent Nybakken,2â€  Vincent J. Carey,1 Lawrence C. Madoff1â€¡
   Channing Laboratory, Brigham Womenâ€™s Hospital, Boston, Massachusetts 02115,1 Department Genetics, Harvard
                                        Medical School, Boston, Massachusetts2
                     Received 8 August 2008/Returned modification 28 September 2008/Accepted 22 November 2008

             pathogens engage host cell surface glycosaminoglycans, redundancy pathogen adhesins host
          glycosaminoglycan-anchoring proteins (heparan sulfate proteoglycans) limited understanding im-
          portance glycosaminoglycan binding infection. alpha C protein group B streptococcus, virulence
          determinant neonatal human pathogen, binds host glycosaminoglycan mediates entry bacteria
          human cells. studied alpha C protein-glycosaminoglycan binding Drosophila melanogaster, glycos-
          aminoglycan repertoire resembles humans genome includes characterized membrane
          heparan sulfate proteoglycan genes. knockdown glycosaminoglycan polymerases heparan sulfate
          proteoglycans reduced cellular binding alpha C protein. interruption alpha C protein-glycosamino-
          glycan binding associated longer host survival lower bacterial burden. data indicate           glycosaminoglycan-alpha C protein interaction involves multiple heparan sulfate proteoglycans impairs bac-
          terial killing. Host glycosaminoglycans, anchored multiple proteoglycans, determine susceptibility           infection. homology Drosophila human glycosaminoglycan/proteoglycan structures
          pathogens express glycosaminoglycan-binding structures, data suggest interfering glycos-
          aminoglycan binding protect infections humans.


   Streptococcus agalactiae (group B streptococcus [GBS]) com-                surface GAGs heparan sulfate (HS) chondroitin sul-
monly colonizes human mucosal surfaces causes devas-                 fate (CS). HS consists iduronic glucuronic acid N-
tating invasive infections, particularly neonates. main                acetylglucosamine, CS consists iduronic glucuronic
identified mammalian host defense GBS opsonophago-                 acid N-acetylgalactosamine. HS CS structures
cytosis, requiring phagocytes, complement, specific antibody.             variable patterns sulfation. groups core
GBS virulence determinants include surface structures                 proteins identified, including syndecans, capsular polysaccharide, cytolysin, protein designated D-             intracytoplasmic associations allowing interactions alanylation lipoteichoic acid (DltA) (10, 22, 25). Protecting          actin cytoskeleton cellular signaling cascades,
organism phagocytosis, capsular polysaccharide high-                glypicans, covalently linked membrane
molecular-weight polymer composed 100 repeating                  lipids glycosylphosphatidylinositol anchor. syn-
pentasaccharide units, terminal sialic acid moiety.               decans carry HS CS chains, glypicans carry
Cytolysin promotes enhanced GBS survival infection                  predominantly HS (7).
contributing phagocyte cytolysis apoptosis helping                 HSPGs expressed widely eukaryotic cell surfaces,
shield GBS oxidative damage (18). Deficiency DltA                  serve important roles diverse processes associated increased susceptibility phagocytosis               cell adhesion, growth factor signaling, tumor biology.
antimicrobial peptides (25).                                                  structures usurped pathogens enter
   Alpha C protein (ACP) important GBS virulence 
                                                                              cells stimulate cell signaling (1, 24). Determining 
terminant binds host cell glycosaminoglycan (GAG)
                                                                              tribution GAG particular HSPG subsequent mediates bacterial entry human cells (3, 4, 5) vitro.
                                                                              events infection outcome especially complex aimed characterize host cell receptor                                                                               cell express multiple HSPGs different HSPG proteins
determine importance ACP-GAG interactions                                                                               display GAG (16, 33). Specifically, vivo.
                                                                              ME180 cell line used prior studies expresses    GAGs highly sulfated modified polysaccharide polymers
                                                                              different HSPGs, making genetic approach mammals anchored cell membrane protein core heparan
sulfate proteoglycan (HSPG). abundant cell                     determine HSPG(s) binds ACP impractical. Drosoph-
                                                                              ila melanogaster attractive determining                                                                               contribution HSPGs infection. organism expresses                                                                               repertoire GAGs similar human cells (32), using
   * Corresponding author. Mailing address: Channing Laboratory,
181 Longwood Ave., Boston, MA 02115. Phone: (617) 525-0752. Fax:              GAG polymerase genes (ttv, DEXT2 [sotv], DEXT3
(617) 731-1541. E-mail: mbaron@partners.org.                                  [botv]) (11, 31) human homologues. D. melanogaster
   â€  Present address: Boston Biomedical Research Institute, 64 Grove          membrane-anchored proteoglycans (syndecan
St., Watertown, MA 02472.
                                                                              [sdc], dally, dally-like protein) (15, 21, 29);    â€¡ Present address: University Massachusetts Medical School, 305
South Street, Jamaica Plain, MA 02130.                                        human homologues. simplicity D. melanogaster sys-
   äŒ¤
     Published ahead print 1 December 2008.                             tem allowed investigate contribution ACP-GAG

                                                                        860
 VOL. 77, 2009                                                             GAG DROSOPHILA SUSCEPTIBILITY INFECTION                                   861


             TABLE 1. Regions targeted dsRNA sequences                     taining epitope binds human cells (2), expressed described
                                                                              previously (2, 5).
                                                                GenBank          Cells. S2 cells grown 25Â°C Schneiderâ€™s medium 10  fetal calf
  Gene                        Base pairs
                                                              accession 
                                                                              serum 1  penicillin-streptomycin (Invitrogen). flow cytometry, cells
ttv                              1â€“634                       NM_057883        incubated Alexa Fluor 488-labeled bovine serum albumin (BSA),
DEXT2                            1â€“535                       NM_166151        ACP, D2-R, D2-R construct charge-neutralizing mutation sdc                            780â€“1088                      NM_057617        putative GAG-binding residue 185, 172, 196 (prepared using kit [Molecular
dally                         1334â€“1649                      NM_079259        Probes]) described previously (4); 10,000 cells sample ana-
dally-like                      95â€“402                       NM_079347        lyzed FACSCalibur instrument (Becton Dickinson) Cellquest soft-
smo                            107â€“1451                      NM_078719        ware. inhibition studies, cells treated heparin sodium chlorate
mnb                           2038â€“2570                      NM_167581        described previously (3, 4).
                                                                                 RNA interference (RNAi). Primers (Table 1) designed guidance
                                                                              data http://www.flyrnai.org/. Control sequences targeted green
                                                                              fluorescent protein (GFP) gene (amplified construct encoding GFP
binding bacterial pathogenesis. binding                 variant GFPuv [Clontech]), smoothened (smo), minibrain (mnb). interaction determines infection outcome Drosophila.                       Megascript kit (Ambion) used synthesize double-stranded RNAs
                                                                              (dsRNAs). cells washed serum-free medium, aliquots 105 cells
                                                                              40 â?®l serum-free medium added 250 ng targeting dsRNA 10
                       MATERIALS METHODS                                  â?®l water. Cells incubated 25Â°C 45 min dsRNA uptake   Bacteria. GBS strain A909 expresses ACP (19). A909/R185A expresses       addition 80 â?®l Schneiderâ€™s medium  fetal calf serum penicillin-
ACP variant point mutation eliminating GAG binding (3, 4). Strains     streptomycin). Cells stained 96 h later.
A909âŒ¬cpsE (14), A909âŒ¬cylE (27), NEM316âŒ¬DltA (NEM1636) (26)              D. melanogaster. Heterozygous mutants generated crossing strain described previously grown Todd-Hewitt broth (THB)      OreR flies flies carrying HSPG mutant alleles dally, sdc, dally
selective antibiotics. ACP D2-R proteins, truncated ACP constructs    dally-like genes. Alleles following sources used.




  FIG. 1. Drosophila model GBS infection.   Male flies infected GBS incubated 29Â°C. Data representative
experiment 30 flies sample shown. Kaplan-Meier log-rank analyses, median survival times flies infected wild-type GBS strains A909 NEM316 21.5 27 h, respectively; strains mutations virulence determinants identified mammalian models (cpsE, cylE, dltA) attenuated Drosophila  median survival times infected flies 43.2, 43.2, 80.2 h,
respectively (P, â¬?0.005 mutant versus parent strain). wt, wild type. (B) Fluorescence-activated cell sorter analysis shows labeled-ACP
binding S2 cells concentration-dependent inhibition soluble heparin. Data shown MFI â«¾ SE cell relative untreated cells, normalized fluorescence cells treated labeled BSA. 500 â?®g/ml heparin, MFI 2.5  â«¾ 0.2  untreated cells (P â«½ 0.001; Studentâ€™s t test). (C) Fluorescence-activated cell sorter analysis shows level S2 cell binding mutant D2-R
constructs charge-neutralizing mutations GAG-binding residues (Arg185, Arg172, Lys196 [D2RâŒ¬185, D2RâŒ¬172, D2RâŒ¬196]) markedly lower level S2 cell binding native D2-R protein. data expressed mean percentage â«¾ SE cells staining
positive indicated protein.
 862       BARON ET AL.                                                                                                                    INFECT. IMMUN.




  FIG. 2. GAG polymerases HSPGs required binding ACP S2 cells.   S2 cells untreated treated dsRNA
sequences targeting GAG polymerase genes ttv, DEXT2 (sotv), ttv DEXT2 (sotv) control sequences targeting GFP
gene, smo (encoding smoothened, transmembrane receptor binds segment polarity protein Hedgehog), mnb (encoding minibrain, serine/threonine protein kinase) prior incubation Alexa Fluor 488-labeled ACP. Data shown MFI â«¾ SE relative sample treated dsRNA targeting GFP repetition experiment. targeting ttv DEXT2 (sotv) polymerase
reduced binding ACP compared cells untreated treated control dsRNA sequences (targeting GFP gene, mnb, smo). targeting ttv (P â«½ 0.06 versus results targeting GFP gene; Studentâ€™s t test) greater effect targeting DEXT2; effect augmented targeting DEXT2 addition ttv (P â¬? 0.001). (B) Drosophila S2 cells untreated treated dsRNA
sequences targeting individual HSPGs (sdc, dally, dally-like protein) HSPGs combination (sdc dally, sdc dally-like protein, dally dally-like protein, sdc, dally, dally-like protein) control sequences (targeting GFP gene, mnb, smo) prior incubation Alexa Fluor 488-labeled ACP. targeting HSPG  combination HSPGs, reduced binding ACP.




   sdc. Bloomington Stock Center numbers 10431 â«½ y[1] w[67c23];P{w[â«¹mC] â«½                similar virulence factors operate Drosophila mam-
lacW} Sdc[k10215]/CyO (Berkeley Drosphila Genome Project),                   mals.
P-element insertion causing mutation sdc, 8585 â«½ w[*]; Df(2R)48,
P{w[â«¹mC] â«½ Ubi-Sara.J}2/CyO, P{w[â«¹mC] â«½ ActGFP}JMR1 (12), sdc
                                                                                            Drosophila S2 cells human cells bind ACP sim-
gene deficiency, used.                                                              ilar characteristics. investigated GBS
   dally. dally80 (8), null allele deletion â«º724 â«¹415, Bloom-       ACP binds D. melanogaster S2 cells, properties
ington Stock Center number 3024â«½ Df(3L)h-i22, h[i22] Ki[1] m[roe-1] p[p]/                phagocytes/macrophages. S2 cells bound fluorescently
TM3, Ser[1], dally gene deficiency, used. homozygous dally80
genotype leads defects distribution signaling Hedgehog,                                                                                          labeled ACP truncated ACP construct (D2-R)
morphogen; dally80 homozygotes die instar larvae.                               containing epitope binds human cells (2). Like
   dally dally-like genes. dally80 dlyA187 constructs (8) carried null alleles   binding human cells (3), binding S2 cells inhibited dally dally-like protein HSPGs; dlyA187 deletion 26                concentration-dependent manner soluble heparin (Fig.
nucleotides resulting reading frameshift amino acid 205, product lacks cysteine-rich region, entire GAG attach-
                                                                                         1B) sodium chlorate, inhibitor cellular sulfate
ment domain, glycosylphosphatidylinositol-anchoring signal.                      incorporation. Specifically, 50 mM sodium chlorate,    GAG polymerase ttv sotv alleles derived strain FRTG13                   mean fluorescence intensity (MFI) â«¾ standard error (SE)
ttv00681 sotv 1.8.1/CyO  kind gift Rahul Warrior) (6). sotv 1.8.1 allele        27.9  â«¾ 1.1  untreated cells (P â¬? 0.001).
generates sotv protein truncated residue 184 lacking catalytic motif.
   Infections. Bacteria grown optical density 650 nm 0.3,       data suggest involvement host cell GAG recep-
concentrations adjusted approximately 1.5 â«» 109 CFU/ml; exact           tor. contrast, binding fluorescent BSA unchanged
stock concentration determined experiment. Male flies 2              treatments. supporting involvement 5 days old anesthetized CO2 pricked dorsal thorax          host GAG receptor results studies showing marked needle dipped THB slurry GBS THB. Flies infected groups 20 30 placed vials food, vials                                                                                          reduction binding S2 cells D2-R constructs incubated 29Â°C. Kaplan-Meier plots derived, median survival              charge-neutralizing mutations GAG-binding
time group determined. Survival curves compared using                residues predicted crystal structure confirmed
log-rank test (20). determine bacterial burden, 10 flies condition       previously human cell studies (4). Specifically, labeled BSA
ground 200 â?®l phosphate-buffered saline (PBS) 0.025  Triton X-100.
Samples spun 3,000 rpm 2 min addition 800 â?®l PBS                                                                                          (negative control) bound 2  cells, D2-R, D2-R 0.025  Triton X-100. Supernatant dilutions plated; colony counts               mutation R185A (D2-R/R185A), D2-R/R172A, compared using Studentâ€™s t test.                                                         D2-R/K196A bound 20.99, 0.14, 0.22, 0.03  cells, 
                                                                                         spectively (Fig. 1C).
                                                                                            GAG polymerases required ACP binding Drosoph-
                                   RESULTS                                               ila S2 cells. determine component(s) GAG-
   GBS causes lethal infection Drosophila using virulence                          HSPG synthesis machinery required ACP-S2 cell
factors identified mammalian models. evaluated                                 binding, depleted GAG expression using RNAi. tar-
Drosophila model infecting adult flies wild-type GBS                             geted GAG polymerase genes ttv DEXT2, prod- GBS variants carrying mutations virulence deter-                             ucts form complex adds alternating N-acetylglucosamine
minants identified previously mammalian infection mod-                                (GlcNAc) glucuronic acid (GlcUA) residues pro-
elsâ€”capsular polysaccharide, cytolysin, DltA (10, 22, 25).                           tein-GAG linkage region DEXT3 initiates HS chain
Flies pricked needles dipped THB survived,                           (11). individual knockdown ttv DEXT2 expression pricked needles dipped slurry wild-type GBS                           (Fig. 2A) decreased ACP binding; ttv knockdown larger
strains died rapidly (Fig. 1A). GBS mutants                              effect (P â«½ 0.06 versus control; Studentâ€™s t test). ttv
attenuated compared wild-type GBS, demonstrating                                 DEXT2 depleted, level ACP binding
 VOL. 77, 2009                                                          GAG DROSOPHILA SUSCEPTIBILITY INFECTION                              863




   FIG. 3. GAG-binding activity ACP promotes GBS virulence.   products Drosophila genes ttv DEXT2 (sotv) form het-
erodimeric GAG-polymerizing complex. generated heterozygous ttv DEXT2 (sotv) mutants crossing strain FRTG13 ttv00681 sotv 1.8.1/CyO wild-type strain OreR. Kaplan-Meier survival plot reveals mutants resisted lethal infection wild-type GBS strain A909 effectively did wild-type OreR flies (P â¬? 0.001). (B) crossed mutant lines OreR generate flies heterozygous mutations HSPGs sdc dally, flies mutations dally dally-like protein sdc, dally, dally-like protein. mutants
resisted infection A909 compared wild-type OreR flies (P, â¬?0.001 versus wild-type results). (C) charge-neutralizing mutation GBS
strain A909/R185A impairs ACP-GAG binding. Kaplan-Meier survival plot shows longer survival fly infection mutant wild-type A909 (median survival times, 26.5 â«¾ 0.04 h A909 infection versus 48 â«¾ 0.04 h A909/R185A infection [P â¬? 0.001; log-rank
test]). Results sterile THB-injected control sample shown. Plots results 70 flies sample.



decreased 14  control cells (P â¬? 0.01 versus                dally-like protein sdc, dally, dally-like protein. Het-
control; Studentâ€™s t test). data indicate ttv/                 erozygotes used homozygous mutants DEXT2 GAG polymerase complex critical ACP binding                      survive adulthood. different alleles sdc S2 cells.                                                                  dally included. contrast wild-type Drosophila,    Drosophila membrane HSPGs contribute ACP-S2 cell                    HSPG mutants resisted infection wild-type GBS (Fig. 3B).
binding. assessed contribution HSPG(s)                      strain heterozygous mutations HSPGs 
ACP binding treating S2 cells RNAi sequences target-                  sisted infection effectively did strains mutations
ing D. melanogaster membrane HSPGs (sdc, dally,                     fewer HSPGs. dally-like protein) comparing binding cells                 GAG binding ACP determines virulence GBS ACP binding untreated cells cells treated              Drosophila. determine specifically importance control RNAi sequences. shown (Fig. 2B), depletion                  ACP-GAG interaction vivo, used GBS strain A909/ HSPG significantly impaired binding ACP S2                      R185A. strain single charge-neutralizing mutation cells.                                                                        ACP specifically eliminates GAG binding reduces
   GAG depletion protects Drosophila infection GBS.                 GBS entry human epithelial cells altering protein determine host GAG polymerases play role                      crystal structure expression changing bac-
susceptibility infection, adult fly mutants alterations            terial growth rate polysaccharide capsule production (4). ttv DEXT2 (sotv) generated. Compound het-                       shown (Fig. 3C), strain A909/R185A attenuated Dro-
erozygotes used homozygotes survive                    sophila compared strain A909 (median fly survival time
adulthood. Wild-type flies susceptible infection                 following infection A909, 26 h, versus 48 h A909/ A909 ttv/sotv mutants (Fig. 3A) (median time                   R185A [P â¬? 0.001; log-rank test]), indicating GAG- survival wild-type flies, 20 h, versus 23 h mutants [P â¬?            binding activity ACP promotes GBS virulence vivo 0.001; log-rank test]), indicating host GAG poly-                  Drosophila.
merases promote GBS virulence.                                                   HSPG deficiency protects Drosophila lethal infection
   HSPG deficiency protects Drosophila infection                    GAG binding-deficient GBS. confirm disrup-
GBS. determine role host HSPGs susceptibility                 tion ACP-GAG binding underlies survival advantage lethal infection, infected adult Drosophila flies expressing                 strain OreR infection A909/R185A compared haploinsufficiency sdc, dally, combination dally             strain OreR infection A909 (ii) HSPG mutant
 864     BARON ET AL.                                                                                                             INFECT. IMMUN.




                                                                             FIG. 5. HSPG mutations associated lower bacterial bur-
                                                                          dens infection.   Wild-type Drosophila (strain OreR) adults
                                                                          infected wild-type GBS strain A909 strain A909/R185A,
                                                                          carries point mutation expresses non-GAG-binding
                                                                          variant ACP. thirty hours later, 10 flies type    FIG. 4. HSPG deficiency confers survival advantage host
                                                                          homogenized PBS 0.025  Triton X-100, samples infected GBS expressing GAG binding-deficient ACP.                                                                           plated. Infections A909/R185A associated lower bac-
crossed HSPG mutant flies strain OreR generate flies                                                                           terial burdens (means, 6 â«» 107 CFU/ml A909 versus 1.2 â«» 107
heterozygous mutations HSPGs, indicated,                                                                           CFU/ml A909/R185A [P â¬? 0.001; Studentâ€™s t test]). (B) OreR infected OreR flies resulting mutants A909/R185A,                                                                           HSPG mutant adult Drosophila flies infected GBS. GBS strain charge-neutralizing mutation impairing ACP-GAG
                                                                          methods bacterial burden OreR flies binding. Mutant flies survived longer OreR flies (median survival
                                                                          higher HSPG mutants (means, 6 â«» 107 CFU/ml OreR
times, â¬Ž100 h mutants versus 48 h OreR flies [P â¬? 0.005;
                                                                          flies versus 2.2 â«» 107 CFU/ml dally80 mutants [P â¬? 0.05] 2.0 â«»
log-rank test]). Flies injected broth survived rates                                                                           107 CFU/ml dally80/dally-like double mutants [P â«½ 0.004]). 90  (data shown).
                                                                          experiment performed times.



flies compared wild-type flies infection A909,                                      DISCUSSION
infected adult Drosophila flies expressing haploinsufficiency sdc, dally, combination dally, dally-like protein,             Structures bind host cell GAG expressed sdc GBS strain A909/R185A, strain charge-                 pathogens. contributions binding interactions neutralizing mutation impairs GAG binding. Heterozy-                 pathogenesis difficult study, 
gote flies used homozygous mutants              dundancy bacterial adhesins mammalian GAG-
survive adulthood. hypothesized survival times                 anchoring proteins. determine role GBS GAG- wild-type OreR HSPG mutant flies sim-                  binding ACP pathogenesis, validated model ilar direct ACP-GAG binding factor influencing            GBS infection Drosophila, organism genome
host survival earlier studies. HSPG mu-              redundancy mammals, showing virulence deter-
tant hosts survived longer wild-type OreR flies (Fig. 4).            minants GBS identified mammalian models promote data potential implications.   GBS               virulence Drosophila. features bind GAG/HSPG non-ACP structures                       ACP-human cell interaction  involvement epitope regions ACP outside mutation area) promote vir-               D2-R region ACP concentration-dependent inhibi-
ulence. (ii) HSPG deficiency promote host survival               tion soluble heparin sodium chlorate [3]) shared mechanisms independent binding bacterial viru-              ACP-Drosophila cell interaction.
lence determinants.                                                          model, cell surface GAG,    Interruption GAG binding associated lower GBS             particular HSPG, confers susceptibility infection. Specifi-
burden. determine HSPGs promote lethal infection                cally, optimal binding Drosophila cells ACP vitro
Drosophila, assessed total bacterial burdens 20 30 h         required GAG polymerase enzymes. vivo, deficiency infection lower GBS colony counts infec-              GAG polymerase enzymes ttv DEXT2 protected flies
tions A909/R185A, strain carrying charge-neutral-              lethal infection. membrane-associated HSPGs
izing mutation impairs GAG binding,              required binding ACP Drosophila cells.
wild-type strain A909 (Fig. 5A). lower numbers              HSPGs (sdc glypican dally) GBS Drosophila flies HSPG haploinsufficiency               required normal Drosophila susceptibility infection wild-type hosts (Fig. 5B). Overall, findings              vivo, suggesting threshold cell surface GAG
support conclusion bacterial survival enhanced             required normal susceptibility infection. Drosophila GAG-bacterial ACP interaction, pro-                  ACP-GAG interaction critical infection outcome motes bacterial entry host cells. absence              model, strain GBS expressing ACP variant Drosophila GAG-bacterial ACP interaction, bacterial killing               single point mutation eliminates ACP-GAG binding fly survival favored.                                             attenuated virulence. prolonged survival HSPG 
 VOL. 77, 2009                                                    GAG DROSOPHILA SUSCEPTIBILITY INFECTION                                   865


ficient flies compared wild-type flies infection     nia newborn mice restored administration mutant GBS strain suggests additional GAG-             soluble GAG heparin. data suggest GAG bind-
binding activity occur outside region muta-         ing specific HSPG activation play significant role
tion ACP GBS structures             outcomes pathogenesis (9, 23), contributions
HSPG deficiency promotes Drosophila host survival             syndecans, glypicans, HSPGs pro-
mechanisms independent binding directly bacterial viru-         cesses described. Drosophila, lence determinants, influencing immune devel-          ACP binding host cell GAG, particular
opment. Lower burdens bacteria seen infected flies         HSPG, promoted bacterial survival host demise. ACP-GAG interaction specifically disrupted           model, interruption ACP-GAG binding enhance controls, suggesting disrupting ACP-GAG binding          bacterial killing keeping bacteria extracellular space
enhances bacterial clearance. vivo findings particu-       killed secreted factors antimi-
larly striking light factors expected bias results   crobial peptides, important component Dro- studies away enhanced survival mutant             sophila defense bacterial infection.
flies:   mutation expected weaken overall host         pathogens engage cells binding host GAG,
health, increasing decreasing death rates         manipulation GAG-binding interactions protect
fection, (ii) studies performed using heterozy-          vulnerable hosts broad range infections. Dro-
gotes, retain functional gene. particular, pre-       sophila model allowed study large sample hosts dict hosts express substantial residual        defects multiple gene products redundant func-
GAG, matrix HSPG core proteins         tions understand importance evolutionarily  Drosophila addition membrane HSPGs               served host GAGs determining host susceptibility infec-
studied  Future work identifying subset spe-         tion. model useful platform dissect cific GAG structures interact ACP facilitate        subtle interactions pathogen host. complex technically challenging goal measuring             studies warranted determine GAG binding
levels particular GAGs wild-type heterozy-        plays similarly significant role mammalian GBS infection
gote mutant hosts.                                                    outcome, GAG-binding interactions deter-
   explanations account finding mul-         outcome infection pathogens tiple HSPGs similarly required ACP-cell binding           Drosophila mammals. ACP-mediated virulence results. possible                                                                                                ACKNOWLEDGMENTS
HSPGs interact directly ACP; instead,  present order unidentified host             work supported National Institutes Health grants
factor develop displayed.  enhanced          AI059495  M.J.B.) AI38424  L.C.M.) March                                                                       Dimes Birth Defects Foundation Basil Oâ€™Connor Starter Scholar
survival Drosophila flies GAG-ACP interac-
                                                                      Award  5-FY06-580  M.J.B.).
tion disrupted modifying residues ACP                 thank Norbert Perrimon, Jennifer Philips, Richard Binari, Chry-
changing expression levels HSPGs suggests direct ACP-          soula Pitsouli, Michele Markstein, Elliott Kieff, Dennis Kasper, Lind-
HSPG interaction. explanation HSPG            say Flax, Huong Ung, David Berry, Gerald Pier, Milan Bajmoczi
expressed different organ vivo (http://flyatlas.org),    discussions, advice, technical assistance. thank Victor Nizet
                                                                      Patrick Trieu-Cuot GBS strains A909âŒ¬cylE NEM1636, decreasing expression predominant HSPG           respectively.
given location dramatically diminish total GAG avail-
                                                                                                      REFERENCES
able bind ACP location. example, dally ex-
                                                                       1. Alvarez-Dominguez, C., J.  Vazquez-Boland, E. Carrasco-Marin, P. Lopez-
pression highest brain sdc expression highest         Mato, F. Leyva-Cobian. 1997. Host cell heparan sulfate proteoglycans larval fat body. Site-specific HSPG expression partially          mediate attachment entry Listeria monocytogenes, listerial
explain findings vivo, S2 cellular RNAi data               surface protein ActA involved heparan sulfate receptor recognition.
                                                                          Infect. Immun. 65:78â€“88.
indicate cell requires HSPGs normal            2. Auperin, T. C., G. R. Bolduc, M. J. Baron,  Heroux, D. J. Filman, L. C.
ACP binding. data suggest HSPG binds                   Madoff, J. M. Hogle. 2005. Crystal structure N-terminal domain
ACP independently HSPG expression patterns                group B Streptococcus alpha C protein. J. Biol. Chem. 280:18245â€“
                                                                          18252. mutually dependent HSPGs form complex                3. Baron, M. J., G. R. Bolduc, M. B. Goldberg, T. C. Auperin, L. C. Madoff. binds ACP absence impairs              2004. Alpha C protein group B Streptococcus binds host cell surface
                                                                          glycosaminoglycan enters cells actin-dependent mechanism.
interaction.                                                              J. Biol. Chem. 279:24714â€“24723.
   studies Drosophila development, different HSPGs           4. Baron, M. J., D. J. Filman, G.  Prophete, J. M. Hogle, L. C. Madoff.
perform redundant functions unique roles                2007. Identification glycosaminoglycan binding region alpha C
                                                                          protein mediates entry group B streptococci host cells. J. Biol.
(13, 30). studies suggest GAG chains mediate                Chem. 282:10526â€“10536. biological effects core proteins mediate             5. Bolduc, G. R., M. J. Baron, C. Gravekamp, C. S. Lachenauer, L. C. (17, 28). mammals, vivo studies              Madoff. 2002. alpha C protein mediates internalization group B
                                                                          Streptococcus human cervical epithelial cells. Cell. Microbiol. 4:751â€“
limited. mammalian cells express numerous                     758.
HSPGs concurrently, distinguishing role GAG           6. Bornemann, D. J., J. E. Duncan, W. Staatz, S. Selleck, R. Warrior. 2004.
                                                                          Abrogation heparan sulfate synthesis Drosophila disrupts Wingless, core protein especially complex. mouse deficient           Hedgehog Decapentaplegic signaling pathways. Development 131:1927â€“ HSPG syndecan-1, susceptibility infection                  1938.
Pseudomonas aeruginosa intraperitoneal inoculation            7. David, G., V. Lories, B. Decock, P. Marynen, J. J. Cassiman, H. Van den
                                                                          Berghe. 1990. Molecular cloning phosphatidylinositol-anchored mem-
normal. Susceptibility reduced model burn-                brane heparan sulfate proteoglycan human lung fibroblasts. J. Cell Biol.
associated sepsis model intranasally induced pneumo-             111:3165â€“3176.
 866       BARON ET AL.                                                                                                                                  INFECT. IMMUN.

 8. Han, C., T. Y. Belenkaya, B. Wang, X. Lin. 2004. Drosophila glypicans               delayed (dally) gene: putative integral membrane proteoglycan required
    control cell cell movement Hedgehog dynamin-independent                  cell division patterning postembryonic development ner-
    process. Development 131:601â€“611.                                                       vous Drosophila. Development 121:3687â€“3702.
 9. Haynes, , III, F. Ruda, J. Oliver,  N. Hamood, J.  Griswold, P. W. Park,    22.   Nizet, V., R. Gibson, C. Rubens. 1997. role group B streptococci
    K. P. Rumbaugh. 2005. Syndecan 1 shedding contributes Pseudomo-                  beta-hemolysin expression newborn lung injury. Adv. Exp. Med. Biol.
    nas aeruginosa sepsis. Infect. Immun. 73:7914â€“7921.                                     418:627â€“630.
10. Hensler, M., G. Liu, S. Sobczak, K. Benirshcke, V. Nizet, G. Heldt. 2005.     23.   Park, P. W., G. B. Pier, M. T. Hinkes, M. Bernfield. 2001. Exploitation
    Virulence role group B Streptococcus beta-hemolysin/cytolysin car-               syndecan-1 shedding Pseudomonas aeruginosa enhances virulence.
    otenoid pigment function neonatal rabbit model early-onset pulmo-               Nature 411:98â€“102.
    nary infection. J. Infect. Dis. 191:1287â€“1291.                                    24.   Pethe, K., S. Alonso, F. Biet, G. Delogu, M. J. Brennan, C. Locht, F. D.
11. Izumikawa, T., N. Egusa, F. Taniguchi, K. Sugahara, H. Kitagawa. 2006.              Menozzi. 2001. heparin-binding haemagglutinin M. tuberculosis     Heparan sulfate polymerization Drosophila. J. Biol. Chem. 281:1929â€“                  required extrapulmonary dissemination. Nature 412:190â€“194.
    1934.                                                                             25.   Poyart, C., E. Pellegrini, M. Marceau, M. Baptista, F. Jaubert, M. C. Lamy,
12. Johnson, K. G.,  Ghose, E. Epstein, J. Lincecum, M. B. Oâ€™Connor, D.               P. Trieu-Cuot. 2003. Attenuated virulence Streptococcus agalactiae
    Van Vactor. 2004. Axonal heparan sulfate proteoglycans regulate distri-             deficient D-alanyl-lipoteichoic acid increased susceptibility     bution efficiency repellent slit midline axon guidance. Curr.         defensins phagocytic cells. Mol. Microbiol. 49:1615â€“1625.
    Biol. 14:499â€“504.                                                                 26.   Poyart-Salmeron, C., C. Carlier, P. Trieu-Cuot, et al. 1990. Transferable
13. Johnson, K. G.,  P. Tenney,  Ghose,  M. Duckworth, M. E. Higashi, K.              plasmid-mediated antibiotic resistance Listeria monocytogenes. Lancet
    Parfitt, O. Marcu, T. R. Heslip, J. L. Marsh, T. L. Schwarz, J. G. Flanagan,            335:1422â€“1426.
    D. Van Vactor. 2006. HSPGs Syndecan Dallylike bind                27.   Pritzlaff, C. , J. C. Chang, S. P. Kuo, G. S. Tamura, C. E. Rubens, V.
    receptor phosphatase LAR exert distinct effects synaptic develop-                Nizet. 2001. Genetic basis beta-haemolytic/cytolytic activity group
    ment. Neuron 49:517â€“531.                                                                B Streptococcus. Mol. Microbiol. 39:236â€“247.
14. Jones, , R. Needham,  Clancy, K. Knoll, C. Rubens. 2003. Penicillin-      28.   Rawson, J. M., B. Dimitroff, K. G. Johnson, X. Ge, D. Van Vactor, S. B.
    binding proteins Streptococcus agalactiae: novel mechanism evasion             Selleck. 2005. heparan sulfate proteoglycans Dally-like Syndecan
    immune clearance. Mol. Microbiol. 47:247â€“256.                                        distinct functions axon guidance visual assembly Dro-
15. Khare, N., S. Baumgartner. 2000. Dally-like protein, new Drosophila               sophila. Curr. Biol. 15:833â€“838.
    glypican expression overlapping wingless. Mech. Dev. 99:199â€“202.        29.   Spring, J., S. E. Paine-Saunders, R. O. Hynes, M. Bernfield. 199